BMO Capital Markets upgraded shares of Ralliant (NYSE:RAL – Free Report) to a hold rating in a research note issued to investors on Monday,Zacks.com reports.
Other equities research analysts have also issued reports about the company. Oppenheimer boosted their target price on Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Barclays lifted their price target on shares of Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a research report on Wednesday, May 13th. Citigroup upped their price objective on shares of Ralliant from $70.00 to $81.00 and gave the stock a “buy” rating in a report on Monday, July 13th. Wall Street Zen upgraded shares of Ralliant from a “hold” rating to a “buy” rating in a report on Saturday. Finally, TD Cowen boosted their target price on shares of Ralliant from $55.00 to $70.00 and gave the stock a “buy” rating in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $71.45.
Ralliant Stock Performance
Ralliant (NYSE:RAL – Get Free Report) last issued its quarterly earnings data on Tuesday, May 12th. The company reported $0.57 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.08. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. The firm had revenue of $534.60 million for the quarter. The firm’s revenue was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. Research analysts anticipate that Ralliant will post 2.64 earnings per share for the current fiscal year.
Ralliant Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 8th were paid a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. The ex-dividend date was Monday, June 8th. Ralliant’s dividend payout ratio (DPR) is presently -1.83%.
Hedge Funds Weigh In On Ralliant
Several large investors have recently added to or reduced their stakes in RAL. Danske Bank A S bought a new stake in shares of Ralliant during the fourth quarter valued at approximately $25,000. V Square Quantitative Management LLC bought a new stake in Ralliant in the 4th quarter valued at $26,000. Allworth Financial LP raised its stake in shares of Ralliant by 134.4% in the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after buying an additional 293 shares in the last quarter. Palisade Asset Management LLC bought a new position in shares of Ralliant during the 3rd quarter worth about $26,000. Finally, BOKF NA bought a new position in shares of Ralliant during the 3rd quarter worth about $29,000.
About Ralliant
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
Featured Articles
- Five stocks we like better than Ralliant
- Qualcomm Stock Slides 30%: Buying Opportunity Ahead of July 29 Earnings
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
